Non-Reliance on Previous Financials, Audits or Interim Review
Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.
On May 14, 2012, MusclePharm Corporation's (the "Company") independent registered public accounting firm and the Company's board of directors (the "Board") determined, after consultation with Company management, that the following financial statements contained misstatements: (i) the Company's audited financial statements for the year ended December 31, 2011, filed in an annual report on Form 10-K with the U.S. Securities and Exchange Commission (the "SEC") on April 16, 2012; (ii) the Company's unaudited financial statements for the period ended September 30, 2011, filed in a quarterly report on Form 10-Q with the SEC on November 14, 2011; (iii) the Company's unaudited financial statements for the period ended June 30, 2011, filed in a quarterly report on Form 10-Q with the SEC on August 16, 2012; and (iv) the Company's unaudited financial statements for the period ended March 31, 2011, filed in a quarterly report on Form 10-Q with the SEC on May 23, 2012. The foregoing financial statements contained material misstatements pertaining to the Company's calculation of net sales and presentation of general and administrative expenses. The Company has determined that advertising related credits that were granted to customers fell within the guidance of ASC No. 605-50-55 ("Revenue Recognition" - Customer Payments and Incentives - Implementation Guidance and Illustrations).
The guidance indicates that, absent evidence of benefit to the vendor, appropriate treatment requires netting these types of payments against revenues and not expensing as advertising expense. The Company also noted other credits and discounts that, upon further review, had been previously classified as advertising expense as a component of general and administrative expense that require a reallocation of presentation as amounts to be netted against revenues. The Company's net loss will not be affected by this reallocation in the statement of operations.
The Company reviewed its accounting policies and procedures beginning in early May, 2012, and on May 14, 2012, determined that for all periods referenced above, the presentation of the statement of operations will need to be restated for these reallocations and therefore should not be relied upon.
The Board has discussed the foregoing matters with the Company's independent registered public accounting firm and has authorized and directed the officers of the Company to take the appropriate and necessary actions to restate its audited financial statements for the year ended December 31, 2011, and its unaudited financial statements for t
Please read the entire article before you post foolish comments. "The Company's net loss will not be affected by this reallocation in the statement of operations." This statement, in and of itself, dismisses any accusations of fraud against MSLP. The mistake was a result of a common accounting error. Speaking of mistakes.......It's "Accounting" not "Acounting", 2 C's chief
lol.... who is this guy. It's not accounting fraud if net loss or net gain stays exactly the same. an expense placed in a wrong account is simply a mistake, not fraud. sorry bro, sounds like your trying to short this stock. I would buy to cover soon.. been doing lots of research. my advice to u
Any company that issues misleading financial statements is committing a fraud by definition. If they were not misleading, why would they have to amend? Netting certain expenses against revenues is essentially an attempt to hide the type of expenses from its investors. Even more interesting is the end of day trading yesterday. MSLP has serious issues ahead.
Where theirs smoke theirs fire.This company has been lying since day one. See you sub penny soon.This is being pumped now by some paid sites and when they send it to the free mailers then there selling!